Diltiazem Ointment After LIS: Not Recommended
No, you should not apply diltiazem ointment after lateral internal sphincterotomy (LIS) to speed recovery. The available evidence addresses diltiazem as an alternative to LIS for treating chronic anal fissures, not as an adjunctive post-operative therapy after sphincterotomy has already been performed.
The Evidence Context
The American Gastroenterological Association guidelines 1 clearly position topical calcium channel blockers (including diltiazem) and LIS as separate treatment options for chronic anal fissure, not as complementary therapies. The guideline states that topical therapy aims to "reversibly decrease resting anal pressure" to allow fissure healing without permanent sphincter damage—this is the alternative to surgery, not an addition to it.
Why This Distinction Matters
LIS already achieves permanent sphincter relaxation through surgical division of the internal sphincter. Adding diltiazem post-operatively would:
- Provide redundant sphincter relaxation when the sphincter has already been mechanically divided
- Potentially cause excessive sphincter relaxation, increasing incontinence risk
- Lack any evidence base for this specific indication
What the Research Actually Shows
The comparative studies 2, 3, 4 all evaluate diltiazem versus LIS as competing treatment strategies:
- Combined botulinum toxin A and diltiazem showed 65% healing versus 94% with LIS 2
- Topical diltiazem alone achieved 71% healing versus 96% with LIS 3
- These studies position the treatments as alternatives, not as sequential therapies
One study 5 examined sphincter-relaxing interventions during hemorrhoidectomy (not fissure surgery), comparing internal sphincterotomy performed at the time of hemorrhoidectomy versus post-operative diltiazem application. This showed sphincterotomy was more effective for pain control, but this addresses a different clinical scenario (hemorrhoidectomy, not post-LIS care).
Post-LIS Recovery: What Actually Works
After LIS, standard post-operative care should include 1:
- Fiber supplementation and adequate fluid intake
- Sitz baths for comfort and hygiene
- Topical analgesics for pain control
- Stool softeners to prevent straining
The guideline emphasizes that LIS "rapidly ameliorates symptoms" with "high cure rates and low relapse rates" 1—the surgery itself is the definitive treatment.
Critical Caveat
The risk of adding diltiazem post-LIS is compounding incontinence risk. LIS already carries a risk of "minor, but sometimes permanent, defects in continence" 1. Further pharmacologic sphincter relaxation with diltiazem could theoretically worsen this complication, though no studies have examined this specific scenario (which itself suggests it's not standard practice).
Bottom Line
Diltiazem ointment is a pre-surgical medical management option for patients who want to avoid surgery or have contraindications to LIS. Once you've performed LIS, the sphincter has been permanently altered, and additional chemical sphincter relaxation serves no evidence-based purpose and may increase harm.